Several grants have made to Professor David Adams and his team at the University of Birmingham whose work on immunotherapy-based treatments for primary liver cancer has initally shown very promising results. This work is to continue.
Click here to download information on this work (pdf).
Professor David Adams and colleagues
Harry Corrigan and Helen Morement of AMMF with Professor Adams on a visit to the University of Birmingham laboratories
Professor Adams and colleagues with their assay system
